Overall rank by patents
#2,159
Across all tracked assignees
USPTO PatentsView assignee record — 183 granted patents across 56 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
Panasonic holds 183 US patents across 56 technology areas — rank #2,159 of 50,000 tracked assignees.
Panasonic Healthcare Holdings Co., Ltd. has been granted 183 US utility patents between 2015 and 2018, placing Panasonic Healthcare Holdings Co., Ltd. at rank #2,159 across all assignees tracked by PlainPatent. This portfolio spans 56 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.6 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Panasonic Healthcare Holdings Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 49.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 183 in the 2015–2019 window — a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Panasonic Healthcare Holdings Co., Ltd.'s 10.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 56 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Panasonic Healthcare Holdings Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
Panasonic Healthcare Holdings Co., Ltd.
183 patents
What this shows Panasonic holds 183 patents — placing it at rank #2,159 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Panasonic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 74 | 40.4% |
| 2016 | 42 | 23.0% |
| 2017 | 42 | 23.0% |
| 2018 | 25 | 13.7% |
Top 15 of 56 technology areas
Overall rank by patents
#2,159
Across all tracked assignees
49.4 out of 100
Panasonic Healthcare Holdings Co., Ltd.'s primary CPC class — all holders and yearly trends
See where Panasonic Healthcare Holdings Co., Ltd. ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.